Adeshwar Meditex Limited (BOM:543309)

Market Cap	253.70M -36.0%
Revenue (ttm)	728.75M -2.2%
Net Income	18.93M -13.4%
EPS	1.31 -13.9%
Shares Out	14.43M
PE Ratio	13.41
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,000
Average Volume	18,900
Open	14.25
Previous Close	n/a
Day's Range	14.25 - 17.58
52-Week Range	13.30 - 21.80
Beta	0.83
RSI	49.43
Earnings Date	Feb 11, 2026

About Adeshwar Meditex

Adeshwar Meditex Limited manufactures and exports sterile surgical wound dressing products and medical disposables in India and internationally. It offers sterile wound dressings under PETRONET, PARAHEAL, BACTIGAUZE PLUS, NITROHEAL, PIVIDINE POVITULLE, POVIZOLE, FRAMITULLE, FUSITULLE, CALGINATE-AG SILVINET, HYDRASOOTHE, POLYBANE, and POLYBANE-N brands; combine dressings, including eye pads under the COMBIDRESS and COMBIPAD brands; and gauze dressing and cotton products, such as cotton stockinette, kneecaps, cast paddings under the ORTHOWRAP bra...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1951
• Employees: 26
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543309

Financial Performance

In fiscal year 2025, Adeshwar Meditex's revenue was 837.13 million, an increase of 4.84% compared to the previous year's 798.50 million. Earnings were 20.66 million, an increase of 2.87%.